(Q36278446)

13 August 2017

1 reference

title

Criteria for the use of recombinant human growth hormone in short bowel syndrome (English)

1 reference

13 August 2017

Neha R Parekh

1

1 reference

PubMed ID

16207690

13 August 2017

Ezra Steiger

series ordinal

2

1 reference

13 August 2017

1 October 2005

1 reference

Nutrition in Clinical Practice

13 August 2017

1 reference

13 August 2017

20

1 reference

13 August 2017

5

1 reference

13 August 2017

503-508

1 reference

Management of patients with a short bowel

13 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Enhancing bowel adaptation in short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Experimental approaches: dietary and hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Intestinal rehabilitation and the short bowel syndrome: part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Effects of insulin-like growth factor-I and growth hormone in models of parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Factors enhancing intestinal adaptation after bowel compensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

The trophic action of growth hormone, insulin-like growth factor-I, and insulin on human duodenal mucosa cultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

In vivo and in vitro effects of human growth hormone on rat intestinal ion transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Indications for specific therapy in the rehabilitation of patients with the short-bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

AGA technical review on short bowel syndrome and intestinal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Adaptation following intestinal resection: mechanisms and signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Net digestive absorption and adaptive hyperphagia in adult short bowel patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Interactions between nutrients and peptide growth factors in intestinal growth, repair, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Growth hormone, glutamine, and modified diet for intestinal adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Effect of recombinant human growth hormone and enteral nutrition on short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Nutrition support in clinical practice: review of published data and recommendations for future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

Metabolism of citrulline in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020005503

10.1177/0115426505020005503

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16207690